Related Experiment Video
Updated: Feb 19, 2026

09:29
An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
Published on: July 14, 2023
1.3K
[16p11.2 Microdeletion: first report in Argentina]
Agostina Tardivo1, Bárbara Masotto2, Lucía Espeche2
1Centro Nacional de Genética Médica "Dr. Eduardo E. Castilla", Ciudad Autónoma de Buenos Aires. agostinatardivo@gmail.com.
Archivos Argentinos De Pediatria
|November 1, 2017
Summary
The 16p11.2 microdeletion can cause developmental delays, intellectual disability, and autism spectrum disorder. Clinical outcomes vary, making diagnosis challenging despite genomic testing.
Area of Science:
- Genetics
- Neurodevelopmental Disorders
Background:
- The 16p11.2 microdeletion is a recurrent genetic cause of developmental delay, intellectual disability, and autism spectrum disorder.
- The phenotypic spectrum associated with this microdeletion is highly variable, ranging from severe intellectual disability and congenital anomalies to a normal phenotype.
Observation:
- Genomic testing, such as chromosomal microarray, identifies the 16p11.2 microdeletion.
- Predicting individual patient phenotype based solely on deletion location is challenging due to numerous genomic variants and their potential functional effects.
Findings:
- This report details the clinical findings in two subjects with heterozygous 16p11.2 microdeletions.
- Phenotypic and behavioral characteristics in these subjects influenced diagnostic strategies.
Implications:
- Accurate diagnosis of 16p11.2 microdeletions is crucial for effective patient management and genetic counseling.
- Understanding the variable expressivity of 16p11.2 microdeletions aids in clinical interpretation and counseling.
